A TYPE 1 diabetes drug about to be offered on the NHS is the biggest medical breakthrough against the condition since insulin ...

It’s a development millions of people living with Type 1 diabetes never thought would happen. A new study is showing promising a functional cure for the life-long disease.

The immunotherpay can give children and adults three extra years before they need to use insulin.

Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...

Teplizumab, also known as Tzield and made by Sanofi, is approved for children aged 8 and over and adults who have early-stage ...

NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical-stage regenerative medicine company developing stem-cell-derived therapies, announced the successful completion of its Type B Pre-IND meeting with ...

A new first-of-its-kind treatment which has been found to delay the onset of type 1 diabetes has been approved for use in the ...

SARS-CoV-2 infection is associated with a transient, nonsustained increase in new-onset type 1 diabetes risk among children and adults.

A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...

There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

Insulin has been the mainstay of Type 1 diabetes treatment for years now, assisting individuals in controlling the disease ...

In Gaza, children with type 1 diabetes face deadly insulin and test strip shortages, forcing families to rely on expired ...